These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Whole-exome sequencing detects Thomas-Wilson A; Dharmadhikari AV; Heymann JJ; Jobanputra V; DiMauro S; Hirano M; Naini AB; Ganapathi M Cold Spring Harb Mol Case Stud; 2022 Feb; 8(2):. PubMed ID: 35022222 [TBL] [Abstract][Full Text] [Related]
11. An elderly diabetic patient with McArdle disease and recurrent rhabdomyolysis: a potential association with late hypoinsulinemia? Chocair PR; Mohrbacher S; de Menezes Neves PDM; Pereira LVB; Oliveira ES; Nardotto LL; Bales AM; Sato VAH; Silva SN; Ferreira BMC; Cuvello-Neto AL BMC Geriatr; 2020 Nov; 20(1):451. PubMed ID: 33153458 [TBL] [Abstract][Full Text] [Related]
13. PYGM expression analysis in white blood cells: a complementary tool for diagnosing McArdle disease? de Luna N; Brull A; Lucia A; Santalla A; Garatachea N; Martí R; Andreu AL; Pinós T Neuromuscul Disord; 2014 Dec; 24(12):1079-86. PubMed ID: 25240406 [TBL] [Abstract][Full Text] [Related]
14. Systemic AAV8-mediated delivery of a functional copy of muscle glycogen phosphorylase (Pygm) ameliorates disease in a murine model of McArdle disease. McNamara EL; Taylor RL; Clayton JS; Goullee H; Dilworth KL; Pinós T; Brull A; Alexander IE; Lisowski L; Ravenscroft G; Laing NG; Nowak KJ Hum Mol Genet; 2020 Jan; 29(1):20-30. PubMed ID: 31511858 [TBL] [Abstract][Full Text] [Related]
15. The effect of muscle glycogen phosphorylase (Pygm) knockdown on zebrafish morphology. Migocka-Patrzałek M; Lewicka A; Elias M; Daczewska M Int J Biochem Cell Biol; 2020 Jan; 118():105658. PubMed ID: 31747538 [TBL] [Abstract][Full Text] [Related]
16. McArdle Disease: Update of Reported Mutations and Polymorphisms in the PYGM Gene. Nogales-Gadea G; Brull A; Santalla A; Andreu AL; Arenas J; Martín MA; Lucia A; de Luna N; Pinós T Hum Mutat; 2015 Jul; 36(7):669-78. PubMed ID: 25914343 [TBL] [Abstract][Full Text] [Related]
17. Splice mutations preserve myophosphorylase activity that ameliorates the phenotype in McArdle disease. Vissing J; Duno M; Schwartz M; Haller RG Brain; 2009 Jun; 132(Pt 6):1545-52. PubMed ID: 19433441 [TBL] [Abstract][Full Text] [Related]
18. Single-centre experience on genotypic and phenotypic features of southern Brazilian patients with McArdle disease. Lorenzoni PJ; Werneck LC; Kay CSK; Arndt RC; Silvado CES; Scola RH Acta Neurol Belg; 2020 Apr; 120(2):303-311. PubMed ID: 30415384 [TBL] [Abstract][Full Text] [Related]
19. Manifesting heterozygotes in McArdle disease: a myth or a reality-role of statins. Núñez-Manchón J; Ballester-Lopez A; Koehorst E; Linares-Pardo I; Coenen D; Ara I; Rodriguez-Lopez C; Ramos-Fransi A; Martínez-Piñeiro A; Lucente G; Almendrote M; Coll-Cantí J; Pintos-Morell G; Santos-Lozano A; Arenas J; Martín MA; de Castro M; Lucia A; Santalla A; Nogales-Gadea G J Inherit Metab Dis; 2018 Nov; 41(6):1027-1035. PubMed ID: 29926259 [TBL] [Abstract][Full Text] [Related]
20. McArdle disease: the mutation spectrum of PYGM in a large Italian cohort. Bruno C; Cassandrini D; Martinuzzi A; Toscano A; Moggio M; Morandi L; Servidei S; Mongini T; Angelini C; Musumeci O; Comi GP; Lamperti C; Filosto M; Zara F; Minetti C Hum Mutat; 2006 Jul; 27(7):718. PubMed ID: 16786513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]